Clinical trial

Assessment of Blood Glucose Monitoring Devices With New Insight Features

NCT02929654

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention OneTouch Verio® Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention OneTouch Verio® Flex Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Subject's Own Blood Glucose Meter Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Assessment of Blood Glucose Monitoring Devices With New Insight Features

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-10-01

PhaseNA

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

OneTouch Verio®DEVICE

OneTouch Verio® FlexDEVICE

Subject's Own Blood Glucose MeterDEVICE

Sponsors & collaborators

LifeScanlead sponsor

Mapped research locations

BirminghamUnited Kingdom1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02929654 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.